Lifevantage CorpLFVN

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$6.29
Market cap
$78.7M
P/E
15.5x
Revenue (TTM)
$182.6M
Net income
$5.1M
Dividend yield
3.02%
1-year total return
-35.1%
Net margin
2.8%
Revenue growth
-20.1%
Debt / equity
—

What Lifevantage Corp does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202120222023202420252026
Revenue$220.2M$206.4M$213.4M$200.2M$228.5M$182.6M
Net income$12.9M$3.1M$2.5M$2.9M$9.8M$5.1M
Free cash flow$12.5M$6.4M$3.8M$10.0M$10.5M$6.7M

More on LFVN.

Figures from Lifevantage Corp's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.